Importantly, T-ALL cells treated with these selective kinase blockers displayed reduced levels of ZAP70 and STAT5 activation without significantly altering their total protein levels (Supplemental Figure 11E). The gene discussed is STAT5A; the disease is acute lymphoblastic leukemia.